Answers are grounded in this paper and cite their sources.
Busulfan has been investigated widely for more than three decades leading to a large and precise handling of this agent with numerous studies on activity and pharmacokinetics and pharmacodynamics. In contrast, the behavior of treosulfan is still under investigation and not fully described. The complexity of treosulfan's metabolism and mechanism of action gives rise to the need of a deeper understanding of its pharmacological activity in a context of high-dose chemotherapy. Specifically, there is a great need to better understand its pharmacokinetics/pharmacodynamics relationship.
No takes yet. Share an insight, caveat, or question.
Galaup et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: